Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 13;13:4113–4122. doi: 10.2147/OTT.S245848

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Zhu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Effect of Ibrutinib on wound healing of DU145 and PC3 cells. Wound-healing assay was performed in DU145 cells and PC3 cells in the presence or absence of Ibrutinib for 12, 18 and 24 h. (A) Representative image of wound healing of DU 145 cells; (B) representative image of wound healing of PC3 cells; (C) quantitative comparison of wounded area. Vertical axes: % of wound healed; horizontal axes: time (h). Open bar: control; gray bar: 2.5µM Ibrutinib; dark bar: 5µM Ibrutinib. *P < 0.05; **P < 0.01; ***P < 0.001.